Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04359732 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Assessment of Response to nCRT for GEJ Cancer Using a Fully Integrated PET/MRI

Study acronym: Escape
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Primary completion date changed from estimate of Feb 2, 2026 to Feb 10, 2026 · Start date: May 8, 2020 to May 10, 2020 · Interventions: hybrid PET/MRI (Other) to hybrid PET/MRI (Other) · 2 more Show 5 more changesShow less
    • Primary completion date changed from estimate of Feb 2, 2026 to Feb 10, 2026
    • Start date: May 8, 2020 to May 10, 2020
    • Interventions: hybrid PET/MRI (Other) to hybrid PET/MRI (Other)
    • Eligibility criteria expanded, about 11 words
    • Study description expanded, about 5 words
  2. Primary completion date: Apr 30, 2025 to Feb 2, 2026 Trial status: Recruiting to Active, Not Recruiting · Enrollment target: estimated 155 to confirmed 121 · Completion date: Oct 31, 2025 to Feb 28, 2026 · 1 morev8 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 155 to confirmed 121
    • Completion date: Oct 31, 2025 to Feb 28, 2026
    • Site details revised
  3. Primary completion date: Jan 30, 2025 to Apr 30, 2025 Completion date: Jun 30, 2025 to Oct 31, 2025 · Site details revisedv7 Show 2 more changesShow less
    • Completion date: Jun 30, 2025 to Oct 31, 2025
    • Site details revised
  4. Primary completion date: Oct 30, 2024 to Jan 30, 2025 Completion date: Apr 30, 2025 to Jun 30, 2025v6 Show 1 more changeShow less
    • Completion date: Apr 30, 2025 to Jun 30, 2025
  5. Primary completion date: May 16, 2023 to Oct 30, 2024 Completion date: Jan 2025 to Apr 30, 2025 · Collaborator revised · Study title shortened, about 5 wordsv5 Show 3 more changesShow less
    • Completion date: Jan 2025 to Apr 30, 2025
    • Collaborator revised
    • Study title shortened, about 5 words

    See this version in full on ClinicalTrials.gov ↗

Show 3 earlier versionsHide 3 earlier versions
  1. Start date changed from estimate of May 2020 to May 8, 2020v4
  2. Start date: Apr 2020 to May 2020v3
  3. Study description expanded, about 7 words Study site revised · Eligibility criteria expanded, about 4 words · Study title expanded, about 1 wordv2 Show 3 more changesShow less
    • Study site revised
    • Eligibility criteria expanded, about 4 words
    • Study title expanded, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Evaluate the potential role of PET/MRI as a predictor of esophageal and junctional cancers in response to neoadjuvant chemoradiotherapy (nCRT).
Trial Details
NCT Number NCT04359732
Lead Sponsor IRCCS San Raffaele
Collaborators: Associazione Italiana per la Ricerca sul Cancro
Conditions Esophageal Cancer, Esophageal Neoplasms
Enrollment 121 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov